Ginkgo Bioworks Holdings Inc. (DNA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.001% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2023 | |||||
| ≡ | Viking Global Investors | Add 126.81% | 2,000,000 | 0.50 | |
| Q4 2022 | |||||
| ≡ | Viking Global Investors | Reduce 38.05% | 968,725 | 0.33 | |
| Q3 2022 | |||||
| ≡ | Viking Global Investors | Add 275.99% | 1,868,750 | 1.08 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Reduce 46.95% | 599,276 | 0.27 | |
| Q1 2022 | |||||
| ≡ | Viking Global Investors | Reduce 84.94% | 7,200,000 | 4.74 | |
| ≡ | Chase Coleman - Tiger Global Management | Sell 100.00% | 60,625 | 0.04 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Add 11.92% | 902,804 | 0.87 | |
| Q3 2021 | |||||
| ≡ | Viking Global Investors | Buy | 7,573,574 | 9.77 | |
| ≡ | Chase Coleman - Tiger Global Management | Buy | 60,625 | 0.05 | |
| ≡ | David Einhorn - Greenlight Capital | Sell 100.00% | 19,850 | 0.50 | |
| Q2 2021 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 19,850 | 0.50 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.